ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
71,287.30
-0.23%
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs Yen
156.435
0.04%
Brent Oil
83.125
-0.48%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Novan Inc (NOVN)

  7. Novan Inc (NOVN) ニュース

NOVN

Novan (NOVN)

Novan Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:NOVN
日付受信時刻ニュースソース見出しコード企業名
2024/05/0213 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NOVNNovan Inc
2024/05/0213 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NOVNNovan Inc
2024/05/0213 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NOVNNovan Inc
2024/05/0200 : 49Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
2024/05/0200 : 48Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
2024/05/0200 : 44Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
2024/05/0200 : 41Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
2024/05/0200 : 37Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NOVNNovan Inc
2024/03/2521 : 54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2024/02/2706 : 22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2024/01/3106 : 47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2024/01/2706 : 38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2024/01/0523 : 23GlobeNewswire Inc.Novartis expands production of Pluvicto™ with addition of its largest and most advanced radioligand therapy manufacturing facility in IndianapolisNASDAQ:NOVNNovan Inc
2023/12/2206 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/12/1109 : 30GlobeNewswire Inc.Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)NASDAQ:NOVNNovan Inc
2023/12/0823 : 15GlobeNewswire Inc.Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissionsNASDAQ:NOVNNovan Inc
2023/12/0609 : 16GlobeNewswire Inc.Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNHNASDAQ:NOVNNovan Inc
2023/11/2015 : 15GlobeNewswire Inc.Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASHNASDAQ:NOVNNovan Inc
2023/10/2506 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/10/2106 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/09/0805 : 58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/08/2505 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/07/2705 : 50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/07/1805 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/07/1722 : 23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/07/1721 : 45GlobeNewswire Inc.Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 ProtectionNASDAQ:NOVNNovan Inc
2023/07/0706 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NOVNNovan Inc
2023/06/2807 : 30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NOVNNovan Inc
2023/06/1706 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NOVNNovan Inc
2023/06/1222 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NOVNNovan Inc
 Showing the most relevant articles for your search:NASDAQ:NOVN

最近閲覧した銘柄

COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
NYSE
XOM
Exxon Mobil
AMEX
SPY
SPDR S&P 500
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
CCOM
US500
US 500
CCOM
US30
US 30
NYSE
JPM
JP Morgan Chase
FX
USDGBP
US Dollar vs Sterling
USOTC
RHHBY
Roche (QX)
NASDAQ
NVDA
NVIDIA
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有